Glioma models have provided important insights into human brain cancers. Among the investigative tools, MRI has allowed their characterization and diagnosis.
combination with advanced neuroimaging techniques [10] [11] [12] has led to the identification of imaging biomarkers for the detection of brain cancers and early prediction of therapeutic efficacy. 13 MRI allows non-invasive in vivo monitoring of both tumour growth and response to therapy, and provides detailed structural information on tumour and brain tissue. 14 Morphological features of diffuse gliomas, e.g. tumour location and size, necrosis, peritumoral oedema, heterogeneity, and haemorrhagic foci, can be determined using routine contrast-enhanced T 1 -and T 2 -weighted MRI. Nevertheless, conventional MRI has limited sensitivity and specificity in evaluating early therapeutic effects, in determining histological type and tumour grading and in accurately delineating tumour extent. 15 Contrast-enhanced T 1 -weighted MRI tends to underestimate the diffuse infiltration of glioma cells 16 depending on the blood-brain-barrier integrity at the infiltrative margins. 17 In addition, histological correlation with T 2 -weighted images of gliomas has shown glioma-infiltrating cells beyond the hyper-intense region on T 2 -weighted images. 18 To overcome these limitations, advanced MRI methods sensitive to tissue properties related to brain cancer biology and glioma cell migration have been developed and implemented. 14, 19 Among these, diffusion MRI, 20 which reflects information on the tissue microstructure, potentially allows imaging of glioma-infiltrating cells in the normal brain 21 and the detection of early changes in the tumour microenvironment following treatment. 22 The diffusion-weighted MR signal, which is recorded as a function of diffusion weighting or b value, is affected by the complex composition and the geometric architecture of the investigated tissues. Due to the presence of structural barriers, water diffusion in brain tissue is restricted and/or hindered. Therefore, the diffusion time (Δ) becomes a key parameter for improving the sensitivity of diffusion MRI to tissue microstructure. For longer Δ, water molecules in the brain probe more obstacles and/or barriers over larger spatial scales, which are, however, smaller than the dimensions of a pixel. Moreover, with increasing Δ, diffusion can be considered 'quasi-Gaussian' in normal physiological conditions, and the measured diffusion coefficient shows a rather monotonic behaviour as function of Δ and membrane permeability, 23 which is more visible for shorter diffusion times. 24 Therefore, the measured diffusion coefficient, which reflects tissue characteristics, might change with the tumour progression for longer Δ, thus playing an important role in evaluating healthy and diseased tissues. To our knowledge, no previous studies have reported the effect of Δ on water diffusion in human glioma models, except an in vitro study on glioma cells. 25 By increasing the diffusion time, water molecules probe a wider area of tissue in accordance with the relation (l = (2DΔ) 1/2 ) between the diffusion distance (l) and the diffusion time (Δ). As a consequence, we hypothesize that the diffusion signal at extended Δ will be more sensitive to the small changes in cell density that are characteristic of the slow infiltration of gliomas. This feature is well modelled in the investigated xenografts.
Currently, diffusion-weighted imaging (DWI) 26 and diffusion tensor imaging (DTI) 27, 28 techniques are commonly used to investigate diffuse infiltrative gliomas in both preclinical 29, 30 and clinical settings. 31, 32 These techniques allow the detection of the invasive pathways of glioma cell migration in the brain, which seem to preferentially occur along the myelinated fibres in white matter tracts.
1,33
Using optimized diffusion protocols at 14.1 T, the aim of this study was to identify slow-growing glioma sphere xenografts in their early stages of growth, which are otherwise not visible using conventional 
| Animal preparation for MRI
Mice underwent MRI for the first time 50 days after orthotopic implantation of human glioma sphere cells and then once a week. Control mice (n = 4) were also investigated using the same MRI protocol.
For MRI measurements, each mouse was anaesthetized with isoflurane (4% induction, 1.5-2% maintenance) in a mixture of air:O 2
(1:0.5 l/min induction, 0.7:0.3 l/min maintenance), and placed in a home-built dedicated holder with the head stereotaxically fixed by ear pins and bite bar. Physiological monitoring was performed using an MRI-compatible small animal monitoring and gating system (Model 1025, SA Instruments, Stony Brook, NY, USA). The body temperature was maintained in the range 36.5-37.5°C using a circulating warm water system, and the respiratory rate kept between 60 and 90 bpm by regulating the isoflurane level. of the control group were considered as statistically significant for P < 0.05, as determined with a two-tailed, unpaired Student's t test.
| MRI

| MRS
Spectra of gliomas were acquired during the final MRI session in each mouse. Proton spectra were collected using a short echo-time Metabolite concentrations were quantified using LCModel 41 and absolute concentrations of metabolites were calculated using an unsuppressed water peak as a reference.
Statistically significant levels were accepted for P < 0.05, as determined with a two-way ANOVA followed by the Bonferroni multi-comparison post-tests.
| Immunohistochemistry
All mice were sacrificed approximately 5 months after implantation, when gliomas were sufficiently large (maximum dimension of 2-3 mm) in diffusion-weighted images. Brains were dissected, fixed in formalin (4% buffered formalin) and embedded in paraffin. Tissue All values are mean ± SD.
A missing value (-) indicates no DW images were available for the evaluation of the CNR. 3 | RESULTS
| MRI results
The diffusion time Δ = 80 ms was found to be optimal for identifying the glioma sphere xenografts, as shown from the pilot study CNR data (Table 2 , Figure 1 ). The extension of the lesions was not properly visualized using lower diffusion times, whereas higher Δ led to unacceptably low SNR. Figure 2E , Figure 3E ), shows the extent of the tumour. In contrast, no lesion is visible in the T 2 -weighted images (Figure 2A , Figure 3A ). Figure 5B ) as well as in the ADC ( Figure 4C , Figure 5C ) and DTI maps ( Figure 4D -F, Figure 5D -F), whereas no evidence of tumour is seen in the corresponding T 2 -weighted image ( Figure 4A , Figure 5A ).
Compared with Figure 2 and Figure 3 , tumours grown from both sphere lines are more visible in Figure 4 and Figure 5 at five months after cell injection, due to tumour development. shows only a ventricular enlargement, as in Figure 5A .
The CNR data shown in Figure 6B are displayed as a function of b values (Δ = 80 ms) for images acquired in the last MRI session ( Figure 4 and Figure 6A ). The best tumour contrast is given for both xenografts at a b value equal to 1352 s/mm 2 , the same as given by the pilot study CNR data (Table 2) .
Mean values of the diffusion indices calculated in the tumour (T)
and in the corresponding contralateral (CL) area of each xenograft as and ADC (C) and DTI maps. Due to the highly invasive and diffuse character of this tumour (corresponding histology, Figure 9A ) it is difficult to delineate tumour borders FIGURE 5 In vivo MRI of LN-2540GS glioma sphere xenograft, five months after injection of the cells. well as in the same brain regions of controls are summarized in Table 3 and Table 4 for both xenografts at early stages of tumour development (three months after injection) and at five months after cell injection, respectively.
For both stages of tumour growth, either three months or five months after cell injection (Table 3 and Table 4 , respectively), a significant increase in MD was observed in tumours grown as LN-2669GS xenografts compared with those grown from LN-2540GS cells, with the CL area and with the values obtained from the same brain regions of controls. On the other hand, a significant decrease in FA was observed in both cases (Table 3 and Table 4 (Table 3 and Table 4 , respectively), compared with those in the contralateral area and in the controls.
By comparing the corresponding values of the diffusion indices for each stage of tumour development, either three months (Table 3) or five months after cell injection (Table 4) , the diffusion indices are slightly lower at earlier stages of tumour growth (Table 3) . However, no significant difference was found between each corresponding diffusion indices in the two investigated stages of tumour development.
| MRS results
Proton spectra were measured immediately before sacrificing mice for histological assessment. In Figure 7 , 1 H spectra of a mouse brain from a 
| Immunohistochemical results
In order to assess imaging and spectroscopic results, histological and immunohistochemical analysis was performed on each mouse. Due to the highly invasive nature of the human LN-2669GS cells, the intrace- (Figure 9g ). The high cell density in the compact tumour area is visualized in Figure 9h . Figure 6A and the spectrum reported in Figure 7C were all acquired during the last MRI session, immediately before the mice were euthanized.
It is of note that the two xenografts display a striking difference in cell density, as visualized in Figure 9d ,h, displaying at high magnification an area of human tumour cells (with the same magnification):
the LN-2669GS xenograft ( Figure 9A, d) shows a lower tumour cell density than the LN-2540GS xenograft ( Figure 9B, h ).
In addition, none of the histological sections of both xenografts shows any areas of necrosis, in accordance with imaging results.
| DISCUSSION
We have developed a diffusion MR protocol at 14.1 T for early detection and investigation of human glioma xenografts in mice.
Its performance was documented on human glioma xenografts derived from the sphere lines LN-2540GS and LN-2669GS, As it is well known 38 the advantage of the PGSTE sequence is the use of long diffusion times, avoiding signal loss due to the transverse relaxation time T 2 . On the other hand, its main disadvantage is a loss of 50% of the MR signal. 42 We partly compensated this loss by using the shortest possible T E (22 ms), an ultra-high magnetic field and a small surface coil (dimensions of 21 mm × 14 mm). However, the increase in SNR due to the high magnetic field was reduced by shorter transverse relaxation time T 2 . In addition, larger susceptibility effects due to the high magnetic field made the detection of glioma sphere xenografts even more challenging.
Tumours grown in both xenograft models were not visible on T 2 -weighted images (Figures 2A, 3A , 4A, 5A and 6j), even though glioma-initiating cells was also difficult using contrast-enhanced
During investigation of glioma sphere xenografts by means of diffusion MRI, the first evidence of tumour presence on diffusionweighted images was revealed three months after glioma sphere cell injection for both xenograft models (Figure 2 and Figure 3 ).
The absence of signs of necrosis and haemorrhagic foci in MR images, which was confirmed by histology, underlined the problematic detection of these slowly growing tumours using standard MRI techniques.
Different diffusion properties between glioma xenografts grown from LN-2669GS and LN-2540GS, respectively, were observed at three months (Table 3 ) and five months after cell injection (Table 4) . 
